Anavex Life Sciences Corp (AVXL)

[tredenwater2]

This does raise one question for me, will the FDA wait for the pediatric trial results before considering 2-73 and approve it for all Rett ages or will the FDA approve 2-73 in adults first and then consider pediatric usage.

Should have raised two questions, will the Fda give accelerated approval for Parkinsons with the episodic memory improvement and perhaps biomarkers we are seeing across multiple diseases now? Basically each trial is confirming and building on our Ph 2 a as these arent completely brand new hypothesis we are driving here.

Build the case Dr Missling and then peak early at Alzheimers right before you announce the mother of all partnerships for Alzheimer’s!